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Background: The intra-aortic balloon pump is used worldwide as an anti-ischemic strategy. However, little is
known about the modifications of the graft flowmetry during use of intra-aortic balloon pump.
Methods: An observational study aimed at analyzing transit-time flow measurements during 1:1 intra-aortic bal-
loon pump use and during its cessation in 138 consecutive patients using intra-aortic balloon pump before cor-
onary artery bypass grafting (n ¼ 442 graft segments) was reported.
Results: In normally functioning grafts, the mean diastolic and mean blood flow improved significantly during
1:1 intra-aortic balloon pump use compared with during intra-aortic balloon pump cessation (P<.001), although
mean and diastolic arterial pressures were significantly lower (P ¼ .001). Arterial and sequential saphenous vein
grafts showed greater improvements in mean diastolic and mean flow compared with single venous grafts. Sur-
plus graft flow (defined as mean flow during 1:1 intra-aortic balloon pump use/mean flowwith intra-aortic balloon
pump off) was recorded (surplus graft flow>1) during 1:1 intra-aortic balloon pump use in all normally func-
tioning grafts, with higher values in single arterial or sequential saphenous vein grafts versus single venous grafts
(both P<.001). In the 9 cases of graft failure, the mean diastolic, mean systolic, and mean flow were significantly
lower and the pulsatility index greater, compared with normally functioning grafts (all P .001). Blood flow did
not change appreciably during 1:1 intra-aortic balloon pump use in failed bypass grafts; thus the surplus graft flow
approached 1.
Conclusion: In this analysis, use of intra-aortic balloon pump was associated with improved diastolic and mean
blood flow in bypass grafts. Arterial and sequential grafts were associated with greater improvements in blood
flow and surplus graft flow. Graft failure was associated with poor transit-time flow results, high pulsatility index
values, and absent surplus graft flow.Intra-aortic balloon pump (IABP) use is a common anti-is-
chemic strategy employed in the daily practice.1 Reductions
in IABP-related complications with the use of small cathe-
ters and sheathless techniques2 have spurred the more liberal
use of preoperative IABP support in high-risk coronary ar-
tery bypass grafting (CABG).2,3 Although the main effects
of IABP have been purported to be a decrease in myocardial
oxygen consumption and an increase in coronary perfusion
through diastolic augmentation, few studies have investi-
gated the effects of the IABP on CABG flowmetry.4-7 In
some animal models, diastolic blood flow in the internal tho-
racic artery and descending aorta coronary bypass grafts has
increased less than in the native left anterior descending cor-
onary artery (LAD) and ascending aorta–coronary grafts
during left ventricular assistance, particularly by means of
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doi:10.1016/j.jtcvs.2008.11.04454 The Journal of Thoracic and Cardiovascular SurIABP.4 Another animal study has shown improved blood
flow in both internal thoracic artery and venous conduits,
but only when the IABP was placed in the ascending
aorta—no such effect was noted when the device was placed
in the descending thoracic aorta, as occurs in clinical prac-
tice.5 Still others have reported an anecdotal case of reduced
blood flow in descending aorta coronary grafts with the use
of IABP.6 A recent report of a small series of patients requir-
ing IABP support showed no increase in diastolic pressure in
the native coronary circulation distal to the site of stenosis,
indicating that the major effect of IABP use in high-risk
patients relates more to reductions in oxygen demand by
systolic unloading than to diastolic augmentation of coro-
nary blood flow.7
The aim of the present observational study was to investi-
gate the effects of preoperative IABP assistance on blood
flow within coronary bypass grafts among patients having
CABG during a 3-year period at a single academic institution.
METHODS
Patients
We analyzed data from patients who had CABG at our institution and
who also received preoperative IABP support. Preoperative IABP usegery c July 2009
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CABG ¼ coronary artery bypass grafting
CPB ¼ cardiopulmonary bypass
FEV1 ¼ expiratory volume in 1 second
IABP ¼ intra-aortic balloon pump
LAD ¼ left anterior descending coronary artery
LITA ¼ left internal thoracic artery
OPCABG ¼ off-pump coronary artery bypass
grafting
RCA ¼ right coronary artery
SGF ¼ surplus graft flow
SV ¼ saphenous vein
TTF ¼ transit-time flow
was indicated for patients with 3-vessel disease and 2 of the following:
preoperative left ventricular ejection fraction 30%, left main coronary ar-
tery stem stenosis>90%, chronic occlusion of the 3 main coronary trunks
(LAD, right, and circumflex coronary arteries), tight stenosis (>95%) of the
proximal LAD (before the first septal or diagonal branch), proximal tight
stenosis (>95%) of a dominant right coronary artery (RCA) with remote
branches for the posterior wall of the left ventricle, unstable angina despite
the use of intravenous nitrates and heparin, recent (<7 days) acute myocar-
dial ischemia of the anterolateral left ventricular wall, and acute ongoing
angina or myocardial ischemia with failed percutaneous coronary
intervention.
Surgical Technique
Surgery was performed through a median sternotomy by 2 of the 4 au-
thors. The left internal thoracic artery (LITA) was harvested with low-volt-
age (20 mV) cautery, and side branches were clipped. Proximal dissection
was performed above the first rib. The LITA was anastomosed to the
LAD. The radial artery (RA) was harvested, after obtaining a negative Allen
test, with the aid of a harmonic scalpel (Ethicon Endo-Surgery, Cincinnati,
Ohio), using the variable mode at moderate intensity. Major collateral
branches were controlled with small clips. The RA was used only as
a free graft and was proximally anastomosed to the ascending aorta. All ar-
terial grafts were secured with 2 epicardial stitches using 6–0 polypropylene
on both sides after completion of distal anastomoses.
Saphenous vein (SV) conduits were harvested from the best internal SV
as detected by preoperative echo Doppler scanning. The SV conduits were
never used to construct Y-conduits with the LITA; circumflex and RCA
were the target territories. Single or sequential RA and SV grafting was
left to the surgeon’s discretion.
When cardiopulmonary bypass (CPB) was used, the ascending aorta was
used as the arterial cannulation site. Venous return to the CPB machine was
accomplished through a double-caval cannulation, when associated mitral
surgery was done, or through a double-stage cannula into the right atrium
in all other cases. Proximal anastomoses were done either after aortic cross-
clamp removal (when CPB was employed) or before distal anastomoses
(when off-pump CABG [OPCABG] was performed). The use of CPB
was standardized and included a Dideco tubing set (Mirandola, Modena,
Italy), a 40-mm filter, a Stockert roller pump (Stockert Instrumente, Munich,
Germany), and a hollow-fiber membrane oxygenator (Monolyth, Sorin Bio-
medica, Saluggia, Italy). Heparin (300 U/kg) was given to achieve a target
activated clotting time> 480 s. Systemic temperature was kept between
32C and 34C. Myocardial protection during CPB was achieved with in-
termittent antegrade and retrograde hyperkalemic warm blood cardioplegia.
Total CPB flow was maintained at 2.6 L $ min1 $ m2.The Journal of Thoracic andExposure and stabilization during OPCABGwere achieved with the Oc-
topus-IV tissue stabilizer (Medtronic Inc, Minneapolis, Minn). Lateral wall
vessels were exposed with the aid of the Starfish system (Medtronic Inc).
Visualization was enhanced by use of a surgical blower-humidifier (model
SSVW-002, Surgical Site Visualization Wand, Research Medical, Midvale,
Utah) connected to a regulated CO2 source. Intracoronary shunts were rou-
tinely used, and OPCABGwas not performed with the aid of coronary snar-
ing. When OPCABG was performed, the first grafted vessel was always the
LAD, followed by proximal anastomoses with the SV or RA, and then distal
anastomoses.
Patients having OPCABG received heparin (150 U/kg) to achieve an ac-
tivated clotting time>300 s. Protamine was given at the end of surgery to
reverse the anticoagulant effects of heparin. Blood was recovered intraoper-
atively by means of an autotransfusion device (Autotrans Dideco, Miran-
dola, Modena, Italy) in all cases. Blood transfusion was indicated for
a hemoglobin level<8 g/dL. After surgery, patients received anticoagulation
with enoxaparin, with a target activated partial thromboplastin time>40 s,
TABLE 1. Characteristics of the cohort
Characteristic (n ¼ 138)
Baseline
Mean age (y) 72.1  9.3
Male sex 103 (74.6)
Diabetes mellitus 74 (53.6)
Hypertension 87 (63.0)
Dyslipidemia 71 (51.4)
Chronic obstructive pulmonary disease 83 (60.1)
Prior myocardial infarction (>4 wk) 66 (47.8)
Myocardial infarction within previous 7 d 67 (48.6)
Anterolateral infarction 50 (36.2)
Left ventricular ejection fraction
<30% 35 (25.3)
30%–50% 76 (55.1)
>50% 27 (19.6)
Left main stem stenosis>90% 55 (39.9)
Chronic occlusion, 3 main trunks 39 (28.3)
Proximal LAD stenosis>95% 75 (54.3)
Proximal dominant RCA stenosis>95% 73 (52.9)
Refractory unstable angina* 77 (55.8)
Ongoing infarction or angina; failed percutaneous
intervention
40 (29.0)
TIMI score
LAD 0.67  0.77
Circumflex artery 0.97  0.75
RCA 0.88  0.81
Intraoperative
Off-pump bypass grafting 31 (22.4)
Mitral valvuloplasty 56 (40.6)
Tricuspid valvuloplasty 23 (16.7)
Carotid thromboendarterectomy 11 (8.0)
Minimally invasive ablation for atrial fibrillation 31 (22.5)
Aortic crossclamp time (min) 69.5  22.8
Cardiopulmonary bypass time (min) 112.8  35.6
Postoperative
Intensive therapy unit stay (h) 44.2  22.7
Hospital stay (d)y 7.3  3.9
Data are presented as number (percentage) of patients or mean  standard deviation.
LAD, Left anterior descending coronary artery; RCA, right coronary artery; TIMI,
Thrombolysis In Myocardial Infarction. *Despite treatment with intravenous nitrates,
heparin, or both. yStarting from the day of bypass surgery.Cardiovascular Surgery c Volume 138, Number 1 55
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IABP cessation IABP 1:1 P Improvement,% (95% CI)
Single saphenous vein–OM (n ¼ 47)
Mean diastolic blood flow (mL/min) 38.6  12.4 73.8  11.7 <.001 84.2% (74.1%–92.8%)
Mean flow (mL/min) 20.1  11.1 30.8  16.1 <.001 53.2% (49.4%–57.1%)
Mean systolic flow (mL/min) 11.1  8.6 9.9  7.7 .473 1.1% (3.4%–0.5%)
Pulsatility index 1.76  0.65 3.49  0.66 <.001
Single saphenous vein–RCA territory (n ¼ 55)
Mean diastolic flow (mL/min) 37.2  10.6 78.9  17.9 <.0001 135.2% (95.4%–172.6%)
Mean flow (mL/min) 23.1  7.5 34.7  10.8 <.001 49.2% (45.4%–52.9%)
Mean systolic flow (mL/min) 10.2  6.8 9.5  5.5 .455 1.3% (2.8%–0.4%)
Pulsatility index 1.67  0.74 3.63  0.60 <.001
Sequential saphenous vein (n ¼ 88)*
Mean diastolic flow (mL/min) 69.6  33.8 156.9  73.9 <.001 128.7% (11.2%–173.9%
Mean flow (mL/min) 48.1  23.9 89.4  45.4 <.001 85.8% (82.2%–89.4%)
Mean systolic flow (mL/min) 13.1  8.7 12.4  7.8 .419 0.4% (1.0%–0.5%)
Pulsatility index 1.58  0.64 3.45  0.74 <.001
LITA–LAD (n ¼ 136)
Mean diastolic flow (mL/min) 54.9  22.5 135.7  52.1 <.001 133.4% (108.2%–173.2%)
Mean flow (mL/min) 30.7  17.8 58.5  34.2 <.001 89.9% (86.5%–93.5%)
Mean systolic flow (mL/min) 10.8  8.3 11.0  9.3 .587 0.5% (0.2%–1.2%)
Pulsatility index 1.49  0.52 3.71  0.68 <.001
Radial artery–OM (n ¼ 46)
Mean diastolic flow (mL/min) 62.3  29.3 145.9  62.7 <.0001 130.3% (106.2%–172.4%)
Mean flow (mL/min) 37.2  14.6 71.4  26.8 <.001 92.5% (86.3%–98.8%)
Mean systolic flow (mL/min) 12.2  7.2 11.0  13.8 .523 0.2% (1.3%–0.03%)
Pulsatility index 1.73  0.74 3.83  0.68 <.001
Radial artery–RCA territory (n ¼ 41)
Mean diastolic flow (mL/min) 63.4  20.8 149.6  51.1 <.001 134.2% (78.9%–167.3%)
Mean flow (mL/min) 39.5  13.7 74.0  24.6 <.001 87.2% (80.4%–93.9%)
Mean systolic flow (mL/min) 16.8  9.4 14.9  10.2 .235 0.5% (1.8%–0.6%)
Pulsatility index 1.85  0.68 3.78  0.72 <.001
Sequential radial artery (n ¼ 20)*
Mean diastolic flow (mL/min) 90.6  35.3 221.4  61.8 <.001 167.3% (99.4%–187.3%)
Mean flow (mL/min) 58.3  23.5 109.6  46.3 <.001 87.3% (82.3%–92.4%)
Mean systolic flow (mL/min) 18.3  8.1 17.1  9.4 .287 0.4% (1.5%–0.8%)
Pulsatility index 1.61  0.66 3.44  0.84 <.001
CABG,Coronary artery bypass graft;CI, confidence interval; IABP, intra-aortic balloon pump; LAD, left anterior descending coronary artery; LITA, left internal thoracic artery;OM,
obtuse marginal branches of the left circumflex artery; RCA, right coronary artery; TTF, transit-time flow. *Onto the left circumflex and right coronary artery territories.starting when postoperative bleeding was controlled (usually within 6 hours)
and continuing until postoperative day 3. Aspirin (150 mg) was given daily
beginning on postoperative day 3.
IABP Assistance, Flowmetric Analysis, and
Evaluation of Surplus Graft Flow
To better support hemodynamic function before CABG, institutional policy
called for percutaneous insertion of IABP with the sheathless technique (7F to
7.5F; 34 or 40 mL according to the body surface area; balloon, Datascope
Corp, Fairfield,NJ) through thebest femoral artery before inductionof anesthesia,
with connection to a Datascope pump (Datascope Corp).8,9 Correct placement of
IABPwasassessedbypostoperativechest radiographor transesophageal echocar-
diography. In12patients (8.7%), becauseof severeperipheral diseaseof theaortic
bifurcation, iliac arteries, or femoral arteries, IABPwaspercutaneously introduced
under fluoroscopic guidance with the sheathless technique through the best bra-
chial artery.9 IABPwaswithdrawnwhenhemodynamic stabilitywas restored, de-
finedas a cardiac index2.0L $m2 $min1with onlyminimal inotropic support
(dobutamine or enoximone at 5 mg $ kg1 $ min1).56 The Journal of Thoracic and Cardiovascular SurIt was the aim of this observational study to evaluate the graft flowmetry
during IABP support and during its temporary cessation (control). The
Institutional Review Board approved (December 2004) this study, and
individual consent was obtained in all patients. The transit-time method is
based on the fact that the time required for ultrasound to pass through blood
is slightly longer upstream than downstream. As the ultrasound beam is
wider than the diameter of the vessel lumen, the ultrasound wave will cover
every flow vector in the vessel, thus making the transit-time difference pro-
portional to the true volume of blood flow in milliliters per minute.10 Graft
function was assessed under stable hemodynamic conditions, generally 30
minutes after protamine administration. Flowmetry of the grafts was per-
formed with a transit-time flowmeter (HT313, Transonic, Transonic Sys-
tems Inc, Ithaca, NY). Different probe sizes (2, 2.5, or 3 mm) were
available to avoid distortion or compression of grafts. Skeletonization of
a small segment of the RA and of the LITA was necessary to reduce the
quantity of tissue interposed between the vessel and the probe. The curves
were always coupled with the electrocardiogram tracing to differentiate sys-
tolic from diastolic flow. The following variables were calculated: mean
systolic, mean diastolic, and mean flow (expressed in mL/min), directlygery c July 2009
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Onorati et al Acquired Cardiovascular DiseaseFIGURE 1. Example of improvement in a sequential saphenous coronary artery bypass graft of the mean diastolic and of the mean graft flow by 1:1 intra-
aortic balloon pump (IABP; A) compared with baseline (No IABP; B).derived from the flowmeter, and pulsatility index (derived from maximum
diastolic flow – minimum systolic flow/mean flow). The flow pattern (sys-
tolic, diastolic) was directly derived from the flow curve of the trace.10 Data
from single, sequential, arterial, and venous conduits were recorded. To
evaluate the potential of IABP to recruit surplus graft flow (SGF), transit-
time flow (TTF)measurements were recorded both during 1:1 IABP support
and following 5 minutes of temporary cessation (‘‘IABP off’’). Thus pa-
tients served as their own controls. Systolic, diastolic, and mean arterial
pressures were recorded and compared during 1:1 IABP support and during
its temporary cessation. Percent improvements in mean systolic, mean dia-
stolic, and mean blood flows were calculated. The SGF was calculated from
the mean flow occurring during 1:1 IABP support divided by the mean flow
during temporary cessation.10
Data Collection and Definitions
The following definitions were used: for angina, Canadian Cardiovascu-
lar Society grading; hypertension, systolic blood pressure> 140 mm Hg,
diastolic blood pressure>90 mm Hg, or both, or ongoing treatment with
antihypertensive medication; diabetes mellitus, fasting blood glucose>
140mg/dL on2 occasions or the use of antidiabetic medication (oral drugs
or insulin); chronic obstructive pulmonary disease, Summit database defini-
tions (treatment for chronic pulmonary compromise or a forced expiratory
volume in 1 second [FEV1]<75% of the predicted value or FEV1/forced
vital capacity< 0.7); and left main stem disease,>50% obstruction in
the left main coronary artery stem.
Hospital mortality was defined as death occurring 30 days after sur-
gery; perioperative acute myocardial ischemia, as new Q waves> 0.04
ms, reduction in R waves>25% in 2 leads, or both along with new aki-
netic/dyskinetic segment identified on echocardiography and a peak tropo-
nin I level  3.1 mg/L at 12 hours after surgery11; low-output syndrome, as
hemodynamic compromise or cardiac index<2.0 L/min/m2 in the intensive
therapy unit despite IABP assistance and inotropic support, after correction
of all electrolyte and blood-gas abnormalities, and after adjusting the pre-The Journal of Thoracic andload to its optimal value; respiratory failure, as the need for mechanical
ventilation for >48 hours or for noninvasive ventilation with positive
end-expiratory pressure for>24 hours; acute renal failure, as the need for
continuous venovenous hemofiltration or dialysis; and neurologic compli-
cation, as any focal brain lesion confirmed by clinical findings, computed
tomography, or both or diffuse postoperative encephalopathy, convulsions,
or severely altered mental status. Hospital morbidity was defined as any
complication requiring therapy or causing delayed hospital or intensive ther-
apy unit discharge.
Statistical Analysis
All data were prospectively recorded by means of the institutional data-
base. Statistical analysis was performed with use of the SPSS program for
Windows, version 13.0 (SPSS Inc, Chicago, Ill). Continuous variables are
presented as means standard deviation, and categorical variables are pre-
sented as number (percentage) of patients unless otherwise indicated. Data
were checked for normality before analysis. The paired-sample t test was
used to evaluate differences in continuous variables during 1:1 IABP sup-
port versus during its temporary cessation (‘‘IABP-off’’). One-way analysis
of variance was used to evaluate the significance of differences among types
of bypass grafts. If the F value was significant and variance was homoge-
neous, Tukey’s multiple comparison test was used to assess differences
between individual graft types; otherwise, Tamhane’s T2 test was used.
Two-way analysis of variance for repeated measures was used for compar-
isons within (1:1 IABP vs IABP-off) and between groups (normal-function-
ing versus failed grafts). Categorical variables were analyzed with use of
either the c2 test or Fischer exact test.
RESULTS
Patient Population
Between January 2005 and January 2008, 714 consecu-
tive patients had CABG at our institution. Of these, 138Cardiovascular Surgery c Volume 138, Number 1 57
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older, high-risk CABG population receiving IABP support,
with high prevalences of diabetes, hypertension, chronic
lung disease, and left ventricular dysfunction (Table 1).
A total of 442 grafts on 551 distal anastomoses (109 se-
quential grafts, 333 single grafts) were completed. The item-
ization of graft types for successful procedures is shown in
Table 2. The mean number of grafts per patient was 3.99
(minimum, 3; maximum, 5).
TTF Analysis and GFR
Among the different types of grafts, mean systolic blood
flow did not change significantly during times of 1:1 IABP as-
sistance versus IABP cessation. The mean diastolic flow and
mean flow, however, significantly improved with IABP assis-
tance (Table 2), with values increasing by 84% to 167% and
49% to 92%, respectively, among the various graft types.
Waveform analysis of well-functioning grafts always ruled
out that the increase of flow observed with IABP mainly re-
sulted from an increase of the diastolic flow (Figure 1).
During both 1:1 IABP and IABP cessation, TTF analysis
was accomplished at the same systolic arterial pressures
(104.2  11.7 mm Hg and 104.0  11.8 mm Hg, respec-
tively; P ¼ .168). However, the diastolic mean and mean
flows on TTF analysis were higher during 1:1 IABP support
versus IABP cessation, despite the presence of slightly lower
diastolic and mean arterial pressures (diastolic pressure dur-
ing TTF, 61.7 14.0 mmHg during 1:1 IABP versus 63.5
14.3 mm Hg during IABP cessation; P<.001; mean arterial
pressure during TTF, 75.8  9.4 mm Hg during 1:1 IABP
versus 77.0 9.5 mmHg during IABP cessation; P<.001).
SGF was recruited (SGF>1) during 1:1 IABP in all nor-
mally functioning grafts (Table 3), with significantly higher
SGF noted in arterial versus SV grafts and in sequential ver-
sus single grafts.
There were 9 cases of failed CABG, each of which was re-
sponsible for perioperativemyocardial ischemia (seeHospital
Outcomes, below). Among these grafts, the mean diastolic,
mean systolic, and mean blood flow rates were significantly
lower than those among normally functioning grafts (Table
4). Moreover, the failed grafts showed no improvement in
blood flow during 1:1 IABP (Tables 4 and 5) and a corre-
sponding lack of SGF (Table 5). In all these patients, the de-
tection of poor TTF findings was associated with
corresponding ischemic electrocardiogram and/or echocar-
diographic signs (new akinetic or hypokinetic segments) of
the corresponding myocardial territories. However, we never
redid distal anastomoses in all of them, due to the ‘‘expected’’
poor TTF results (poor distal vessel quality with diffuse and
severe calcified lesions at preoperative angiography).
Hospital Outcomes
Two patients (1.4%) died during hospitalization, 9 pa-
tients (6.5%) had perioperative acute myocardial ischemia,58 The Journal of Thoracic and Cardiovascular SurgTABLE 3. Comparison of SGF in normally functioning bypass grafts,
by graft type
Type of CABG SGF
P values
(post-hoc
analysis)
Single saphenous vein–OM (n ¼ 47) 1.53  0.27
Single saphenous vein–RCA territory .971
Sequential saphenous vein <.001
LITA–LAD <.001
Radial artery–OM <.001
Radial artery–RCA territory <.001
Sequential radial artery <.001
Single saphenous vein–RCA territory (n ¼ 55) 1.49  0.19
Single saphenous vein–RCA territory .971
Sequential saphenous vein <.001
LITA–LAD <.001
Radial artery–OM <.001
Radial artery–RCA territory <.001
Sequential radial artery <.001
Sequential saphenous vein (n ¼ 88)* 1.85  0.35
Single saphenous vein–OM <.001
Single saphenous vein–RCA territory <.001
LITA–LAD .831
Radial artery–OM .657
Radial artery–RCA territory .994
Sequential radial artery .999
LITA–LAD (n ¼ 136) 1.89  0.33
Single saphenous vein–OM <.001
Single saphenous vein–RCA territory <.001
Sequential saphenous vein .831
Radial artery–OM .995
Radial artery–RCA territory .993
Sequential radial artery .999
Radial artery–OM (n ¼ 46) 1.92  0.34
Single saphenous vein–OM <.001
Single saphenous vein–RCA territory <.001
Sequential saphenous vein .657
LITA–LAD .995
Radial artery–RCA territory .931
Sequential radial artery .980
Radial artery–RCA territory (n ¼ 41) 1.87  0.30
Single saphenous vein–OM <.001
Single saphenous vein–RCA territory <.001
Sequential saphenous vein .994
LITA–LAD .993
Radial artery–OM .931
Sequential radial artery .999
Sequential radial artery (n ¼ 20)* 1.87  0.31
Single saphenous vein–OM <.001
Single saphenous vein–RCA territory <.001
Sequential saphenous vein .999
LITA–LAD .999
Radial artery–OM .980
Radial artery–RCA territory .999
CABG, Coronary artery bypass graft; LAD, left anterior descending coronary artery;
LITA, left internal thoracic artery;OM, obtuse marginal branches of the left circumflex
artery; RCA, right coronary artery; SGF, surplus graft flow. *Onto the left circumflex
and right coronary artery territories.ery c July 2009
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Failed grafts Successful grafts
IABP cessation IABP 1:1 P IABP cessation P*
All failed grafts (n ¼ 9)
Mean diastolic flow (mL/min) 6.5  3.2 6.2  4.5 .343 83.5  21.7 <.001
Mean flow (mL/min) 4.6  0.8 4.7  0.9 .312 34.9  20.2 <.001
Mean systolic flow (mL/min) 8.5  1.8 8.1  1.5 .535 11.2  7.7 .042
Single saphenous vein–OM (n ¼ 2)
Mean diastolic flow (mL/min) 5.0  2.2 5.5  3.6 .585 38.6  12.4 <.001
Mean flow (mL/min) 4.7  1.7 5.1  1.8 .090 20.1  11.1 .001
Mean systolic flow (mL/min) 7.4  2.6 8.1  3.3 .217 11.1  8.6 .038
Pulsatility index 5.4  0.6 5.9  0.4 .205 1.76  0.65 <.001
Single saphenous vein– CA (n ¼ 2)
Mean diastolic flow (mL/min) 6.0  1.4 6.3  2.5 .223 37.2  10.6 <.001
Mean flow (mL/min) 4.4  0.5 4.3  0.1 .656 23.1  7.5 <.001
Mean systolic flow (mL/min) 7.9  1.6 8.1  5.5 .331 10.2  6.8 .041
Pulsatility index 4.4  0.5 5.2  0.3 .374 1.67  0.74 <.001
LITA–LAD (n ¼ 2)
Maximum flow (mL/min) 5.2  2.0 5.4  4.2 .414 54.9  22.5 <.001
Mean flow (mL/min) 3.7  0.6 3.9  0.6 .205 30.7  17.8 <.001
Minimum flow (mL/min) 8.2  0.5 8.3  1.5 .505 10.8  8.3 .040
Pulsatility index 5.7  0.1 6.1  0.1 .090 1.49  0.52 <.001
IABP, Intra-aortic balloon pump; LAD, left anterior descending coronary artery; LITA, left internal thoracic artery;OM, obtuse marginal branches of the left circumflex artery; RCA,
right coronary artery; TTF, transit-time flow. *Compared with during IABP cession in failed bypass grafts.and 11 patients (8.0%) had postoperative low-output syn-
drome. The 9 cases of acute myocardial ischemia reflected
failed grafting of a single SV on the RCA territory (n ¼
2), single SV on obtuse branches (n ¼ 2), sequential SV
(n ¼ 1), LITA-to-LAD (n ¼ 2), single RA on the RCA ter-
ritory (n ¼ 1), and single RA on the first obtuse marginal
branch (n ¼ 1). These data were further confirmed by post-
operative coronary angiographies, which were accom-
plished during the same hospitalization (n ¼ 3 patients) or
during the first 30 days (n ¼ 6 patients) following surgery.
Twenty-three patients (16.7%) required noninvasive ven-
tilation because of respiratory insufficiency, 4 patients
(2.9%) had postoperative acute renal failure, and 2 patients
(1.4%) had neurologic complications. Except for 1 patient
suffering from stroke, all of these patients recovered com-
pletely and were discharged home.
Three patients (2.2%) had IABP-related complications,
of which 2 were considered minor. The only major IABP-The Journal of Thoracic andrelated complication was a case of brachial artery thrombo-
sis in a patient with transbrachial support, which required
immediate IABP withdrawal and embolectomy. The patient
recovered completely, however, and was discharged home.
DISCUSSION
The main effects of IABP have been purported to be a de-
crease in myocardial oxygen demand through reduced after-
load and ventricular wall stress and an increase in coronary
perfusion through diastolic augmentation.1 The literature
supports the former hypothesis, but the data on coronary
(or possibly collateral) blood flow enhancement are incon-
sistent.7,12-14 Yoshitani and coworkers7 recently reported
a reduction in oxygen demand through decreased afterload,
but no augmentation of diastolic coronary flow, by measur-
ing intracoronary pressure distal to coronary stenosis in hu-
mans. Moreover, few data exist on the effects of IABP on
flow within bypass grafts, most of which have been obtainedTABLE 5. Change in blood flow (95% CI) and SGF in failed bypass grafts, by graft type
Change in blood flow
Mean diastolic (%) Mean (%) Mean systolic (%) SGF
Single saphenous vein–OM (n ¼ 2) 10.1 (6.2–19.4) 7.6 (4.5–19.7) 13.2 (8.5–17.5) 1.08  0.01
Single saphenous vein–RCA (n ¼ 2) 5 (0.4–8.2) 2.9 (71.4–65.5) 2.5 (2.2–15.2) 0.97  0.08
Sequential saphenous vein (n ¼ 1)* 2.5 3.8 3.7 0.96
LITA–LAD (n ¼ 2) 3.5 (3.5–9.1) 4.2 (9.2–27.6) 1.5 (1.5–4.6) 1.04  0.03
Radial artery–OM (n ¼ 1) 2.5 1.9 1.5 1.02
Radial artery–RCA (n ¼ 1) 3.3 3.9 5.6 1.04
CI, Confidence interval; LAD, left anterior descending coronary artery; LITA, left internal thoracic artery; OM, obtuse marginal branches of the left circumflex artery; RCA, right
coronary artery; SGF, surplus graft flow. *Both left circumflex and right coronary artery territories.Cardiovascular Surgery c Volume 138, Number 1 59
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Acquired Cardiovascular Disease Onorati et alfrom animal models.4,5,15 Tedoriya and coworkers4 have
shown that diastolic flow in internal thoracic artery and de-
scending aorta coronary grafts increased less than in native
LAD and ascending aorta coronary grafts during left ventric-
ular assistance in dogs, particularly with IABP. In another
animal model, Gitter and colleagues5 showed that blood
flow was improved in both internal thoracic artery and ve-
nous conduits when IABP was placed in the ascending aorta
but not when placed in the descending thoracic aorta. Tsu-
chida and coworkers6 have reported a case of reduced flow
with IABP placement in the descending aorta in a patient
with a descending aorta coronary graft. One study in humans
has shown increased blood flow in SV grafts with the aid of
IABP, but this was parallel to an increase in mean aortic
pressure.15
Our study showed an increase in bypass graft diastolic and
mean blood flow during IABP as used in clinical practice,
with no increase in mean systemic arterial pressure. Accord-
ingly, IABP assistance appears to increase diastolic (and
therefore mean) graft flow parallel to a reduction in after-
load, as confirmed by reduced systemic diastolic pressure.
Moreover, the absence of SGF recruitment appears to be
an early marker of graft malfunction. Under hypoxic condi-
tions, myocardial performance depends on flow in the coro-
nary arteries and/or bypass grafts.16,17 During cardiogenic
shock, isolated reduction of afterload does not significantly
improve myocardial function—enhanced coronary driving
pressure, and therefore perfusion, are necessary to reverse
ventricular failure.16,17 Further, treatment with inotropes
and vasodilators (and inodilators) increase left ventricular
work without increasing myocardial perfusion and actually
reduce coronary flow by decreasing diastolic perfusion pres-
sures.16,18 Again, our observational study showed signifi-
cant increases in mean diastolic and mean blood flow in
bypass grafts—–without increases in mean systolic flow—
despite concomitant reductions in systemic diastolic arterial
pressure (afterload reduction) induced by IABP. Therefore,
augmentation of diastolic blood flow can be purported to
be one of the main effects of IABP in patients having
CABG, although experimental animal models with pres-
sure-volume loops are necessary to better define such topic.
Our findings conflict with those of Tsuchida and col-
leagues6 and Kimura and coworkers,19 who noted that
IABP use was not associated with improved coronary flow
distal to sites of stenosis. Our results can be attributed to
the fact that normally functioning bypass grafts, by defini-
tion, would circumvent mechanical obstructions to coronary
flow caused by stenosis.
Internal thoracic artery grafts have been shown to carry
the best long-term patency rates and provide the greatest sur-
vival and event-free survival benefits.20 Recent series also
have shown that arterial revascularization improves out-
comes of CABG, regardless of the type of arterial con-
duit.1,10,21,22 Arterial grafting also may enhance resistance60 The Journal of Thoracic and Cardiovascular Surto the development of atherosclerosis,23 and it offers the pos-
sibility of ideal coronary-to-conduit size matching.24 Little is
known about the intraoperative behavior of arterial grafts
compared with SV grafts, however. TTF analysis with
IABP provides an opportunity to explore the SGF associated
with different types of bypass grafts.
In our study, the SGF was larger in arterial conduits than
in single SV grafts. The principal determinant of the degree
of patency late after CABG has been shown to be the rate of
blood flow through the graft. Both Faulkner and associates25
and Rittgers and colleagues26 have reported a strict inverse
association between flow rate and intimal proliferation. It
can be speculated that the higher the flow, the longer the pa-
tency, although experimental studies are necessary to further
investigate this topic.
The variables used to estimate flow rate are the diameter
and resistance of the graft and the resistance posed by the na-
tive coronary vessel. Given that the diameters of SV grafts
are relatively constant for a given patient and that the resis-
tance posed by an SV graft is negligible compared with that
of its coronary counterpart, the resistance of the native cor-
onary vessels remains the principal determinant of flow
rate.27 Thus if the individual resistance levels of the grafted
arteries are assumed to be equivalent, a double sequential
graft poses only half the resistance of an individual graft.
Single SV grafts therefore would be more resistant than se-
quential conduits and would be expected to confer lesser pa-
tency than would sequential grafts.27 This hypothesis also
explains the findings of O’Neill and colleagues27 and Gron-
din and coworkers,28 who found better patency with the
proximal anastomoses of sequential grafts compared with
the individual grafts. This same phenomenon would apply
to consideration of sequential RA grafting.
In conclusion, IABP exerts a benefit in patients having
CABGby improving diastolic blood flow through functioning
bypass grafts, parallel to a reduction in afterload.However, ex-
perimental animal models with pressure-volume loops are
necessary to clearly define the effects of IABP on cardiac
work, oxygen consumption, and coronary resistances.
The combination of IABP and TTF technology can help
in early detection of malfunctioning grafts through demon-
stration of the absence of SGF. Single arterial bypass grafts
and sequential SV grafts were associated with greater SGF
values than were single SV grafts, offering a potential expla-
nation for the survival advantage reported with these graft
types.
References
1. Baskett RJ, Ghali WA, Maitland A, Hirsch GM. The intraaortic balloon pump in
cardiac surgery. Ann Thorac Surg. 2002;74:1276-87.
2. Menon P, Totaro P, Youhana A, Argano V. Reduced vascular complication after
IABP insertion using smaller catheter and sheathless technique. Eur J Cardio-
thorac Surg. 2002;22:491-2.
3. Gutfinger DE, Ott RA,Miller M, Selvan A, Codini MA, Alimadadian H, et al. Ag-
gressive preoperative use of intraaortic balloon pump in elderly patients undergo-
ing coronary artery bypass grafting. Ann Thorac Surg. 1999;67:610-3.gery c July 2009
A
C
D
Onorati et al Acquired Cardiovascular Disease4. Tedoriya T, Kawasuji M, Sakakibara N, Takemura H, Watanabe Y, Hetzer R.
Coronary bypass flow during use of intraaortic balloon pumping and left ventric-
ular assist device. Ann Thorac Surg. 1998;66:477-81.
5. Gitter R, Cate CM, Smart K, Jett GK. Influence of ascending versus descending
balloon counterpulsation on bypass graft blood flow. Ann Thorac Surg. 1998;65:
365-70.
6. Tsuchida M, Yamato Y, Watanabe T, Ohzeki H, Hayashi J. Changes in graft flow
pattern from the descending aorta due to intraaortic balloon pump. Ann Thorac
Surg. 2000;70:981-2.
7. Yoshitani H, Akasaka T, Kaji S, Kawamoto T, Kume T, Neishi Y, et al. Effects of
intraaortic balloon counterpulsation on coronary pressure in patients with stenotic
coronary arteries. Am Heart J. 2007;154:725-31.
8. Onorati F, Presta P, Fuiano G, Mastroroberto P, Comi N, Pezzo F, et al. A ran-
domized trial of pulsatile perfusion using an intraaortic balloon pump versus non-
pulsatile perfusion on short-term changes in kidney function during
cardiopulmonary bypass during myocardial reperfusion. Am J Kidney Dis.
2007;50:229-38.
9. Onorati F, Impiombato B, Ferraro A, Comi MC, Spaccarotella C, Indolfi C, et al.
Transbrachial intraaortic balloon pumping in severe peripheral atherosclerosis.
Ann Thorac Surg. 2007;84:264-6.
10. Walpoth BH, Bosshard A, Genyk I, Kipfer B, Berdat PA, Hess OM, et al. Transit-
time flow measurement for detection of early graft failure during myocardial re-
vascularization. Ann Thorac Surg. 1998;66:1097-100.
11. Onorati F, Pezzo F, Comi MC, Impiombato B, Esposito A, Polistina M, et al. Ra-
dial artery graft function is not affected by age. J Thorac Cardiovasc Surg. 2007;
134:1112-20.
12. Bolooki H. Current status of circulatory support with intraaortic balloon pump.
Cardiol Clin. 1985;3:123-33.
13. Flynn MS, Kern MJ, Donohue TJ, Aguirre FV, Bach RG, Caracciolo EA. Alter-
ations of coronary collateral blood flow velocity during intraaortic balloon pump-
ing. Am J Cardiol. 1993;71:1451-5.
14. Kern MJ, Aguirre F. Coronary flow alternans: a unique examination of coronary
physiology and influence of intraaortic balloon pumping. Am Heart J. 1992;123:
1369-73.
15. Bolotin G, van der Veen FH, Lorusso R, Wolf T, Sachner R, Shofti R, et al. He-
modynamic analysis of descending versus ascending aortomioplasty, and compar-
ison with intraaortic balloon pump. Eur J Cardiothorac Surg. 2002;21:975-80.The Journal of Thoracic and16. Bregman D, Kripke DC, Goetz RH. The effects of synchronous unidirectional
intraaortic balloon pumping on hemodynamics and coronary blood flow in
cardiogenic shock. Trans Am Soc Artif Intern Organs. 1970;16:439-46.
17. Kuhn LA, Kline HJ, Marano AJ, Hamby RI, Cestero J, Cohn LJ, et al. Mechanical
increase of vascular resistance in experimental myocardial infarction in shock.
Circ Res. 1966;19:1086-96.
18. Dormandy JA, Goetz RH, Kripke DC. Hemodynamics and coronary blood flow
with counterpulsation. Surgery. 1969;65:311-20.
19. Kimura A, Toyota E, Lu S, Goto M, Yada T, Chiba Y, Ebata J, et al. Effects of
intraaortic balloon pumping on septal arterial blood flow velocity waveform dur-
ing severe left main coronary artery stenosis. J Am Coll Cardiol. 1996;27:810-6.
20. Lytle BW, Blackstone EH, Loop FD, Houghtaling PL, Arnold JH, Akhrass R,
et al. Two internal thoracic artery grafts are better than one. J Thorac Cardiovasc
Surg. 1999;117:855-72.
21. Kurlansky PA, Williams DB, Traad EA, Carrillo RG, Schor JS, Zucker M, et al.
Arterial grafting results in reduced operative mortality and enhanced long-term
quality of life in octogenarians. Ann Thorac Surg. 2003;76:418-27.
22. Verma S, Szmitko PE, Weisel RD, Bonneau D, Latter D, Errett L, et al. Should
radial arteries be used routinely for coronary artery bypass grafting? Circulation.
2004;110:40-6.
23. Ruengsakulrach P, Sinclair R, Komeda M, Raman J, Gordon I, Buxton B. Com-
parative histopathology of radial artery versus internal thoracic artery and risk fac-
tors for development of intimal hyperplasia and atherosclerosis. Circulation.
1999;100(suppl 2):139-44.
24. Ascione R, Underwood MJ, Lloyd CT, Jeremy JY, Bryan AJ, Angelini GD. Clin-
ical and angiographic outcome of different surgical strategies of bilateral internal
mammary artery grafting. Ann Thorac Surg. 2001;72:959-65.
25. Faulkner SL, Fisher RD, Conkle DM, Page DL, Bender HW Jr. Effect of blood
flow rate on subendothelial proliferation in venous autografts used as arterial sub-
stitutes. Circulation. 1975;52(suppl I):163-72.
26. Rittgers SE, Karayannacos PE, Guy JF, Nerem RM, Shaw GM, Hostetler JR, et al.
Velocity distribution and intimal proliferation in autologous vein grafts in dogs.
Circ Res. 1978;42:792-801.
27. Vural KM, Sener E, Tasdemir O. Long term patency of sequential and individual
saphenous vein coronary bypass grafts. Eur J Cardiothorac Surg. 2001;19:140-4.
28. Grondin CM, Limet R. Sequential anastomoses in coronary artery grafting: techni-
cal aspects and early and late angiographic results. Ann Thorac Surg. 1977;23:1-8.Cardiovascular Surgery c Volume 138, Number 1 61
